Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer. | Cell Rep | 2022 | 35905726 | PubTator, text mining | PubMed |
| JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies. | Front Cell Dev Biol | 2022 | 35903543 | PubTator, text mining | PubMed |
| Low-Dose-Rate Radiation-Induced Secretion of TGF-β3 Together with an Activator in Small Extracellular Vesicles Modifies Low-Dose Hyper-Radiosensitivity through ALK1 Binding. | Int J Mol Sci | 2022 | 35897723 | PubTator, text mining | PubMed |
| IRIDA Phenotype in TMPRSS6 Monoallelic-Affected Patients: Toward a Better Understanding of the Pathophysiology. | Genes (Basel) | 2022 | 35893046 | PubTator, text mining | PubMed |
| Functions of the bone morphogenetic protein signaling pathway through non-coding RNAs. | Noncoding RNA Res | 2022 | 35892126 | PubTator, text mining | PubMed |
| A Targeted Next-Generation Sequencing Panel to Genotype Gliomas. | Life (Basel) | 2022 | 35888045 | PubTator, text mining | PubMed |
| A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients. | Cancers (Basel) | 2022 | 35884472 | PubTator, text mining | PubMed |
| BMP3 inhibits TGFβ2-mediated myofibroblast differentiation during wound healing of the embryonic cornea. | NPJ Regen Med | 2022 | 35879352 | PubTator, text mining | PubMed |
| Chemical Replacement of Noggin with Dorsomorphin Homolog 1 for Cost-Effective Direct Neuronal Conversion. | Cell Reprogram | 2022 | 35877103 | PubTator, text mining | PubMed |
| The fifth edition of the World Health Organization Classification of Tumors of the Central Nervous System: Implications for cancer registries. | Neuro Oncol | 2022 | 35877072 | PubTator, text mining | PubMed |
| Tumor-Associated Microenvironment of Adult Gliomas: A Review. | Front Oncol | 2022 | 35875065 | PubTator, text mining | PubMed |
| The Ubiquitin-Proteasome System in Apoptosis and Apoptotic Cell Clearance. | Front Cell Dev Biol | 2022 | 35874820 | PubTator, text mining | PubMed |
| A Process for the Design and Development of Novel Bone Morphogenetic Protein-7 (BMP-7) Mimetics With an Example: THR-184. | Front Pharmacol | 2022 | 35873578 | PubTator, text mining | PubMed |
| Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis. | Leukemia | 2022 | 35869266 | PubTator, text mining | PubMed |
| Activin B promotes the initiation and progression of liver fibrosis. | Hepatol Commun | 2022 | 35866567 | PubTator, text mining | PubMed |
| Contemporary perspectives on heterotopic ossification. | JCI Insight | 2022 | 35866484 | PubTator, text mining | PubMed |
| Case Report: Unable to Jump Like a Kangaroo Due to Myositis Ossificans Circumscripta. | Front Vet Sci | 2022 | 35865877 | PubTator, text mining | PubMed |
| Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK2. | ACS Med Chem Lett | 2022 | 35859885 | PubTator, text mining | PubMed |
| Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial. | J Bone Miner Res | 2022 | 35854638 | PubTator, text mining | PubMed |
| Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003. | Clin Cancer Res | 2022 | 35852795 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=29